Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
Steven N. Seyedin, Jonathan E. Schoenhals, Dean A. Lee, et al.
Immunotherapy (2015) Vol. 7, Iss. 9, pp. 967-980
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Breaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer Theranostics
Wenpei Fan, Wei Tang, Joseph Lau, et al.
Advanced Materials (2019) Vol. 31, Iss. 12
Closed Access | Times Cited: 161
A review on lymphocyte radiosensitivity and its impact on radiotherapy
Harald Paganetti
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 43
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Hari Menon, Rishab Ramapriyan, Taylor R. Cushman, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 134
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
Dean A. Lee, Cecele J. Denman, Gabriela Rondón, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 7, pp. 1290-1298
Open Access | Times Cited: 132
Checkpoint inhibitors in breast cancer – Current status
Anne Dyhl-Polk, Inge Marie Svane, Michael Andersson, et al.
Cancer Treatment Reviews (2017) Vol. 63, pp. 122-134
Closed Access | Times Cited: 131
Oxygen‐Enriched Metal‐Phenolic X‐Ray Nanoprocessor for Cancer Radio‐Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy
Wei Sang, Lisi Xie, Guohao Wang, et al.
Advanced Science (2020) Vol. 8, Iss. 4
Open Access | Times Cited: 129
Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and Risk/Benefit Analysis
Jean‐Pierre Pouget, Alexandros G. Georgakilas, Jean‐Luc Ravanat
Antioxidants and Redox Signaling (2018) Vol. 29, Iss. 15, pp. 1447-1487
Open Access | Times Cited: 127
PARP Inhibitors in Ovarian Cancer
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, et al.
Recent Patents on Anti-Cancer Drug Discovery (2018) Vol. 13, Iss. 4, pp. 392-410
Open Access | Times Cited: 125
Roadmap: proton therapy physics and biology
Harald Paganetti, Chris Beltran, Stefan Both, et al.
Physics in Medicine and Biology (2020) Vol. 66, Iss. 5, pp. 05RM01-05RM01
Open Access | Times Cited: 123
Review: Immune‐Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
María E. Suarez‐Almazor, Sang T. Kim, Noha Abdel‐Wahab, et al.
Arthritis & Rheumatology (2017) Vol. 69, Iss. 4, pp. 687-699
Open Access | Times Cited: 111
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
Dawei Chen, Hari Menon, Vivek Verma, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000492-e000492
Open Access | Times Cited: 82
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
Changju Qu, Nana Ping, Liqing Kang, et al.
Journal of Immunotherapy (2019) Vol. 43, Iss. 1, pp. 32-37
Closed Access | Times Cited: 75
Results and challenges of immune checkpoint inhibitors in colorectal cancer
Sheik Emambux, Gaëlle Tachon, Audelaure Junca, et al.
Expert Opinion on Biological Therapy (2018) Vol. 18, Iss. 5, pp. 561-573
Closed Access | Times Cited: 67
Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials
Vivek Verma, Taylor R. Cushman, Uğur Selek, et al.
International Journal of Radiation Oncology*Biology*Physics (2018) Vol. 101, Iss. 5, pp. 1141-1148
Closed Access | Times Cited: 65
Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma
Pravin Kesarwani, Antony Prabhu, Shiva Kant, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 15, pp. 3632-3643
Open Access | Times Cited: 62
Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
Emmanuel Donnadieu, Loı̈c Dupré, Lia Gonçalves Pinho, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 4, pp. 1067-1079
Open Access | Times Cited: 61
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy
Paul A. Beavis, Clare Y. Slaney, Michael H. Kershaw, et al.
Seminars in Immunology (2015) Vol. 28, Iss. 1, pp. 64-72
Closed Access | Times Cited: 63
Potentiating prostate cancer immunotherapy with oncolytic viruses
Patrick Lee, Shashi Gujar
Nature Reviews Urology (2018) Vol. 15, Iss. 4, pp. 235-250
Closed Access | Times Cited: 59
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model
Sharareh Niknam, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5735-5743
Open Access | Times Cited: 54
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease
Hanna Kemeny, Aladine A. Elsamadicy, S. Harrison Farber, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 5, pp. 1141-1151
Open Access | Times Cited: 51
Stereotactic Body Radiotherapy for Oligometastasis
Rohann Correa, Joseph K. Salama, Michael T. Milano, et al.
The Cancer Journal (2016) Vol. 22, Iss. 4, pp. 247-256
Closed Access | Times Cited: 47
Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges
Luyao Wang, Mei Dou, Qingxia Ma, et al.
International Immunopharmacology (2019) Vol. 74, pp. 105695-105695
Closed Access | Times Cited: 45
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
Aesha I. Ali, Amanda J. Oliver, Tinaz Samiei, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 44
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy
Jonathan E. Schoenhals, Steven N. Seyedin, Chad Tang, et al.
The Cancer Journal (2016) Vol. 22, Iss. 2, pp. 130-137
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top